Vitrolife AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011205202
SEK
139.20
-5.5 (-3.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
871.00
842.00
959.00
867.00
941.00
841.00
904.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
871.00
842.00
959.00
867.00
941.00
841.00
904.00
Raw Material Cost
428.00
422.00
441.00
425.00
442.00
423.00
452.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.00
10.00
43.00
18.00
25.00
24.00
15.00
Selling and Distribution Expenses
273.00
237.00
268.00
223.00
235.00
226.00
230.00
Other Expenses
2.30
1.50
-1.50
1.10
0.10
0.80
1.20
Total Expenditure (Excl Depreciation)
729.00
684.00
737.00
677.00
703.00
681.00
709.00
Operating Profit (PBDIT) excl Other Income
142
158
222
190
238
160
195
Other Income
-6.00
-9.00
8.00
-15.00
-6.00
7.00
-9.00
Operating Profit (PBDIT)
242.00
256.00
342.00
290.00
341.00
272.00
295.00
Interest
5.00
10.00
43.00
18.00
25.00
24.00
15.00
Exceptional Items
0.00
0.00
-5.00
-1.00
-15.00
0.00
-4,300.00
Gross Profit (PBDT)
443.00
420.00
518.00
442.00
499.00
418.00
452.00
Depreciation
106.00
107.00
112.00
115.00
109.00
105.00
109.00
Profit Before Tax
132.00
141.00
182.00
156.00
192.00
143.00
-4,130.00
Tax
32.00
41.00
43.00
40.00
49.00
28.00
49.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
100.00
101.00
139.00
116.00
143.00
115.00
-4,179.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
100.00
101.00
139.00
116.00
143.00
115.00
-4,179.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-1.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
100.00
100.00
139.00
116.00
143.00
115.00
-4,179.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Reserves
13,281.00
13,125.00
13,639.00
13,137.00
13,096.00
13,231.00
12,722.00
Earnings per share (EPS)
0.74
0.74
1.02
0.86
1.06
0.85
-30.87
Diluted Earnings per share
0.74
0.74
1.02
0.86
1.06
0.85
-30.87
Operating Profit Margin (Excl OI)
16.3%
18.76%
23.15%
21.91%
25.29%
19.02%
21.57%
Gross Profit Margin
27.32%
29.45%
30.66%
31.26%
31.99%
29.49%
-444.8%
PAT Margin
11.48%
12.0%
14.49%
13.38%
15.2%
13.67%
-462.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 3.44% vs -12.20% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -28.06% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -6.42% vs -20.66% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -50.00% vs -76.74% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Vitrolife AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
871.00
3,646.00
-2,775.00
-76.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
871.00
3,646.00
-2,775.00
-76.11%
Raw Material Cost
428.00
2,304.00
-1,876.00
-81.42%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.00
83.00
-78.00
-93.98%
Selling and Distribution Expenses
273.00
682.00
-409.00
-59.97%
Other Expenses
2.30
35.50
-33.20
-93.52%
Total Expenditure (Excl Depreciation)
729.00
3,424.00
-2,695.00
-78.71%
Operating Profit (PBDIT) excl Other Income
142.00
222.00
-80.00
-36.04%
Other Income
-6.00
13.00
-19.00
-146.15%
Operating Profit (PBDIT)
242.00
376.00
-134.00
-35.64%
Interest
5.00
83.00
-78.00
-93.98%
Exceptional Items
0.00
-16.00
16.00
100.00%
Gross Profit (PBDT)
443.00
1,342.00
-899.00
-66.99%
Depreciation
106.00
141.00
-35.00
-24.82%
Profit Before Tax
132.00
136.00
-4.00
-2.94%
Tax
32.00
30.00
2.00
6.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
100.00
106.00
-6.00
-5.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
100.00
106.00
-6.00
-5.66%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
100.00
106.00
-6.00
-5.66%
Equity Capital
0
0
0.00
Face Value
0.20
0.50
0.00
Reserves
13,281.00
9,086.00
4,195.00
46.17%
Earnings per share (EPS)
0.74
0.28
0.46
164.29%
Diluted Earnings per share
0.74
0.28
0.46
164.29%
Operating Profit Margin (Excl OI)
16.30%
6.09%
0.00
10.21%
Gross Profit Margin
27.32%
7.60%
0.00
19.72%
PAT Margin
11.48%
2.91%
0.00
8.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 87.10 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 3.44% vs -12.20% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -7.44% vs 3.98% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -28.06% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -30.07% vs 34.91% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -6.42% vs -20.66% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -28.53% vs 15.28% in Jun 2024

Quarterly - Interest
Interest 0.50 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -50.00% vs -76.74% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -80.00% vs -52.83% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.30%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024